The interplay between amylin and amyloid-β (Aβ) protein pathologies is an intriguing area of study that sheds light on the complex relationship between neurodegenerative diseases like Alzheimer’s disease (AD) and metabolic disorders such as type 2 diabetes (T2D). The gene discussed is IAPP; the disease is early-onset autosomal dominant Alzheimer disease.